Molecule to Medicine Recognised Across Five Great Place To Work® Categories in 2026

At Molecule to Medicine (MTM), we believe that groundbreaking drug discovery relies as much on culture as it does on scientific rigor. In 2026, direct, anonymous feedback from our team through the Great Place To Work® Trust Index© survey resulted in national recognition across five distinct workplace categories.

This multi-category recognition highlights our commitment to building an environment where every individual feels valued, supported, and empowered to advance their career.

A Comprehensive Benchmark of Workplace Culture

The Great Place To Work® evaluation assesses core dimensions of the employee experience, including trust in leadership, equity, work-life balance, and professional development. In 2026, MTM earned spots on the following national lists within the Small Organisations category:

• UK’s Best Workplaces™ 2026: Reflecting overall employee trust, organisational pride, and camaraderie across our UK hubs.
• UK’s Best Workplaces for Women™ 2026: Recognising our commitment to gender representation, equal opportunity, and equitable career pathways in STEM.
• UK’s Best Workplaces for Wellbeing™ 2026: Highlighting initiatives that support work-life balance, psychological safety, and employee wellbeing.
• UK’s Best Workplaces for Development™ 2026: Honouring our focus on continuous learning, mentorship, and internal career progression.
• UK’s Best Workplaces in BioPharma™ 2026: Validating our position as a preferred employer within the UK life sciences sector.

Key Insights From the 2026 Trust Index© Survey

The independent survey results provide a clear snapshot of life at MTM compared to standard industry benchmarks:

• 94% of employees state MTM is a great place to work, compared to 54% at a typical UK company.
• 100% agreement that employees are treated fairly regardless of gender or race.
• 100% of respondents reported feeling pride in team accomplishments and collective outcomes.
• 100% rate MTM as a physically safe, welcoming, and inclusive work environment.

Benedict Gautrey, Managing Director of Great Place To Work® UK, noted:

“This recognition is no mean feat and highlights companies across the UK that excel in fostering high levels of trust in leadership, instilling pride in their workforce, and cultivating strong camaraderie among colleagues.”

Andrea Nisbet, Chief People Officer at MTM comments:

"These recognitions reflect the culture we have built together, one founded on trust, inclusion and opportunity. I am immensely proud of our people, whose passion and commitment make Molecule to Medicine an exceptional place to work."

How Culture Drives Scientific Impact

A collaborative, agile workplace directly strengthens our mission to create next generation medicines.  By providing expert drug discovery capabilities paired with operational infrastructure, MTM empowers its teams to establish, scale, and support our global portfolio of biotech companies.

Our award-winning culture spans MTM’s active portfolio, including Melio Bio, Curlew Bio, Pathios Therapeutics, Lucia Bio, and ThirtyFiveBio with additional stealth opportunities under evaluation.

To explore our active biotech portfolio, visit www.moleculetomedicine.com/portfolio.

Get in Touch

To learn more about MTM’s collaborative approach to scaling biotech ventures, contact us at enquiries@m2m.bio

‍